CXCL9 and hepatocellular carcinoma: In HCC, CXCL9 is associated with the recruitment of tumor-infiltrating immune cells (mainly CD4+ and CD8+ lymphocytes) shaping the TME and possibly amplifying anti-tumor responses of cytotoxic T cells [31].